Annual Retained Earnings
-$574.10 M
-$151.76 M-35.93%
December 31, 2023
Summary
- As of February 25, 2025, AKRO annual retained earnings is -$574.10 million, with the most recent change of -$151.76 million (-35.93%) on December 31, 2023.
- During the last 3 years, AKRO annual retained earnings has fallen by -$364.57 million (-174.00%).
- AKRO annual retained earnings is now -12478.79% below its all-time high of -$4.56 million, reached on December 31, 2017.
Performance
AKRO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$756.13 M
-$72.70 M-10.64%
September 30, 2024
Summary
- As of February 25, 2025, AKRO quarterly retained earnings is -$756.13 million, with the most recent change of -$72.70 million (-10.64%) on September 30, 2024.
- Over the past year, AKRO quarterly retained earnings has dropped by -$237.22 million (-45.72%).
- AKRO quarterly retained earnings is now -773.48% below its all-time high of -$86.56 million, reached on December 31, 2018.
Performance
AKRO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AKRO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.9% | -45.7% |
| 3 y3 years | -174.0% | -172.1% |
| 5 y5 years | -563.2% | -559.2% |
AKRO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.0% | at low | -143.7% | at low |
| 5 y | 5-year | -340.5% | at low | -480.2% | at low |
| alltime | all time | <-9999.0% | at low | -773.5% | at low |
Akero Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$756.13 M(+10.6%) |
| Jun 2024 | - | -$683.43 M(+8.9%) |
| Mar 2024 | - | -$627.44 M(+9.3%) |
| Dec 2023 | -$574.10 M(+35.9%) | -$574.10 M(+10.6%) |
| Sep 2023 | - | -$518.91 M(+8.3%) |
| Jun 2023 | - | -$479.25 M(+6.9%) |
| Mar 2023 | - | -$448.17 M(+6.1%) |
| Dec 2022 | -$422.34 M(+36.1%) | -$422.34 M(+5.8%) |
| Sep 2022 | - | -$399.28 M(+9.8%) |
| Jun 2022 | - | -$363.74 M(+8.1%) |
| Mar 2022 | - | -$336.33 M(+8.4%) |
| Dec 2021 | -$310.30 M | -$310.30 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -$277.88 M(+9.6%) |
| Jun 2021 | - | -$253.55 M(+12.9%) |
| Mar 2021 | - | -$224.62 M(+7.2%) |
| Dec 2020 | -$209.53 M(+60.8%) | -$209.53 M(+16.5%) |
| Sep 2020 | - | -$179.82 M(+13.5%) |
| Jun 2020 | - | -$158.41 M(+11.4%) |
| Mar 2020 | - | -$142.21 M(+9.1%) |
| Dec 2019 | -$130.32 M(+50.5%) | -$130.32 M(+13.6%) |
| Sep 2019 | - | -$114.71 M(+15.7%) |
| Jun 2019 | - | -$99.16 M(+7.9%) |
| Mar 2019 | - | -$91.93 M(+6.2%) |
| Dec 2018 | -$86.56 M(+1796.7%) | -$86.56 M |
| Dec 2017 | -$4.56 M | - |
FAQ
- What is Akero Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Akero Therapeutics?
- What is Akero Therapeutics annual retained earnings year-on-year change?
- What is Akero Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Akero Therapeutics?
- What is Akero Therapeutics quarterly retained earnings year-on-year change?
What is Akero Therapeutics annual retained earnings?
The current annual retained earnings of AKRO is -$574.10 M
What is the all time high annual retained earnings for Akero Therapeutics?
Akero Therapeutics all-time high annual retained earnings is -$4.56 M
What is Akero Therapeutics annual retained earnings year-on-year change?
Over the past year, AKRO annual retained earnings has changed by -$151.76 M (-35.93%)
What is Akero Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AKRO is -$756.13 M
What is the all time high quarterly retained earnings for Akero Therapeutics?
Akero Therapeutics all-time high quarterly retained earnings is -$86.56 M
What is Akero Therapeutics quarterly retained earnings year-on-year change?
Over the past year, AKRO quarterly retained earnings has changed by -$237.22 M (-45.72%)